Latest from Oxehealth

25
November
2022
Oxehealth selected as Financial Times 2022 Healthcare Tech Champion
21
November
2022

This year, the newspaper invited readers to name European companies using new technology to meet today’s business challenges.

08
April
2022
Oxehealth Listed in CB Insights’ Top Digital Health Companies of 2021
13
December
2021

CB Insights have just unveiled their third annual Digital Health 150 — a ranking of the 150 most promising digital health start-ups in the world, all using digital technology to transform healthcare.

08
April
2022
Oxehealth and our partners win awards at the National Positive Practice in Mental Health Awards
07
October
2021

Two of our partner trusts walked away with awards for their successful implementation of Oxevision

08
April
2022
Oxehealth & Partners Scoop 3 HSJ Partnership Awards!
29
June
2021

Not once, not twice...but thrice!

08
April
2022
FDA grants Oxehealth Vital Signs De Novo clearance; Oxehealth launches in the US
31
March
2021

Oxehealth has announced another world first after the US Food and Drug Administration granted a De Novo clearance for its Oxehealth Vital Signs product.

08
April
2022
Oxehealth's Charlotte Wood named one of twelve innovators selected to scale across England’s NHS with support from the NHS Innovation Accelerator
08
March
2021

Oxehealth's Oxevision named one of 12 high impact innovations to join the NHS Innovation Accelerator in 2021.

Hey! We think you’re in Sweden.

Sweden

This is our site for the UK market, do you want to visit our Swedish site?
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
cross
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.